Effects of cyclopentenone prostaglandins and related compounds on insulin-like growth factor-I and Waf1 gene expression

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1397, Issue 1, 1998, Pages 31-42

  Bui, Tim ^a   Straus, Daniel S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclopentenone; Diethyl maleate; Insulin like growth factor I; Prostaglandin; Waf1

Indexed keywords

BUTHIONINE SULFOXIMINE; CYCLOPENTENONE; PROSTAGLANDIN; PROSTAGLANDIN A1; PROSTAGLANDIN A2; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN J2; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE REPRESSION; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYCLOPENTANES; GLIOMA; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INSULIN-LIKE GROWTH FACTOR I; MALEATES; METHYL METHANESULFONATE; PROSTAGLANDINS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; UBIQUITINS;

ANIMALIA;

EID: 0032054755     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4781(97)00214-5     Document Type: Article

References (47)

1. 2-antitumour and anti-viral activities and mechanisms involved. Eicosanoids. 3:1990;189-199.
2. 2 and related compounds: an update. Prostaglandins Leukotrienes Essent. Fatty Acids. 47:1992;1-12.
3. Sasaki H., Fukushima M. Prostaglandins in the treatment of cancer. Anti-Cancer Drugs. 5:1994;131-138.
4. 1 arrest and pre-clinical results. Ann. NY Acad. Sci. 744:1994;161-165.
5. 2 against HTLV-I-infected MT-2 cells. Int. J. Cancer. 51:1992;481-488.
6. 2. Mol. Cell. Biol. 16:1996;762-770.
7. 2: a growth-dependent response mediated by activation of heat shock transcription factor. Mol. Cell. Biol. 12:1992;1528-1534.
8. Amici C., Sistonen L., Santoro M.G., Morimoto R.I. Anti-proliferative prostaglandins activate heat shock transcription factor. Proc. Natl. Acad. Sci. USA. 89:1992;6227-6231.
9. 2 results in elevated expression of gadd153 mRNA. Exp. Cell Res. 199:1992;85-89.
10. 2 specifically represses IGF-I gene expression in C6 rat glioma cells. Endocrinology. 138:1997;985-993.
11. 2-induced growth arrest. FASEB J. 8:1994;1048-1054.
12. 2 on c-myc expression and cell cycle progression in human leukemia cell line HL-60. Cancer Res. 48:1988;2813-2818.
13. 1 phase by prostaglandins. FEBS Lett. 270:1990;15-18.
14. 2 is a ligand for the adipocyte determination factor PPARγ Cell. 83:1995;803-812.
15. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell. 83:1995;813-819.
16. Yu K., Bayona W., Kallen C.B., Harding H.P., Ravera C.P., McMahon G., Brown M., Lazar M.A. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270:1995;23975-23983.
17. Brun R.P., Tontonoz P., Forman B.M., Ellis R., Chen J., Evans R.M., Spiegelman B.M. Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev. 10:1996;974-984.
18. Forman B.M., Chen J., Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ Proc. Natl. Acad. Sci. USA. 94:1997;4312-4317.
19. Rossi A., Elia G., Santoro M.G. 2-Cyclopenten-1-one, a new inducer heat shock protein 70 with anti-viral activity. J. Biol. Chem. 271:1996;32192-32196.
20. 1 and glutathione catalyzed by homogeneous glutathione-S-transferases from human and rat liver. Biochim. Biophys. Acta. 398:1975;205-208.
21. Honn K.V., Marnett L.J. Requirement of a reactive α,β-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by 'A' series prostaglandins. Biochem. Biophys. Res. Commun. 129:1985;34-40.
22. 2. Biochemistry. 29:1990;3760-3765.
23. 2 with intracellular glutathione and enhancement of its anti-proliferative activity by glutathione depletion. Cancer Res. 50:1990;1879-1885.
24. 2-glutathione conjugate in L1210 mouse leukemia cells. Biochem. Pharmacol. 43:1992;1053-1060.
25. Lowe W.L. Jr., Meyer T., Karpen C.W., Lorentzen L.R. Regulation of insulin-like growth factor-I production in rat C6 glioma cells: possible role as an autocrine/paracrine growth factor. Endocrinology. 130:1992;2683-2691.
26. Trojan J., Blossey B.K., Johnson T.R., Rudin S.D., Tykocinski M., Ilan J., Ilan J J. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor-I. Proc. Natl. Acad. Sci. USA. 89:1992;4874-4878.
27. Resnicoff M., Burgaud J.L., Rotman H.L., Abraham D., Baserga R. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor-I receptors. Cancer Res. 55:1995;3739-3741.
28. Murphy L.J., Bell G.I., Duckworth M.L., Friesen H.G. Identification, characterization, and regulation of a rat complementary deoxyribonucleic acid which encodes insulin-like growth factor-I. Endocrinology. 121:1987;684-691.
29. Huppi K., Siwarski D., Dosik J., Michieli P., Chedid M., Reed S., Mock B., Givol D., Mushinski J.F. Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1). Oncogene. 9:1994;3017-3020.
30. Fornace A.J. Jr., Alamo I., Hollander M.C., Lamoreaux E. Ubiquitin mRNA is a major stress-induced transcript in mammalian cells. Nucleic Acids Res. 17:1989;1215-1230.
31. Straus D.S., Burke E.J., Marten N.W. Induction of insulin-like growth factor binding protein-1 gene expression in liver of protein-restricted rats and in rat hepatoma cells limited for a single amino acid. Endocrinology. 132:1993;1090-1100.
32. Straus D.S., Takemoto C.D. Effect of fasting on insulin-like growth factor-I (IGF-I) and growth hormone receptor mRNA levels and IGF-I gene transcription in rat liver. Mol. Endocrinol. 4:1990;91-100.
33. Straus D.S., Takemoto C.D. Effect of dietary protein deprivation on insulin-like growth factor (IGF)-I and -II, IGF binding protein-2, and serum albumin gene expression in rat. Endocrinology. 127:1990;1849-1860.
34. Straus D.S., Burke E.J. Glucose stimulates IGF-I gene expression in C6 glioma cells. Endocrinology. 136:1995;365-368.
35. Boyland E., Chasseaud L.F. Enzymes catalysing conjugation of glutathione with α,β-unsaturated carbonyl compounds. Biochem. J. 109:1968;651-660.
36. Trezl L., Park K.S., Kim S., Paik W.K. Studies on in vitro S-methylation of naturally occurring thiol compounds with N-methyl-N-nitrosourea and methyl methanesulfonate. Environ. Res. 43:1987;417-426.
37. Beranek D.T., Weis C.C., Swenson D.H. A comprehensive quantitative analysis of methylated and ethylated DNA using high pressure liquid chromatography. Carcinogenesis. 1:1980;595-606.
38. 2. J. Biol. Chem. 258:1983;11713-11718.
39. 2 formed in human plasma. Proc. Natl. Acad. Sci. USA. 81:1984;1317-1321.
40. 2-mediated growth inhibition. Biochem. Biophys. Res. Commun. 139:1986;808-815.
41. 2 formation and characterization of its synthetases in various tissues of adult rats. Arch. Biochem. Biophys. 260:1988;521-531.
42. 2 generation after activation of rat and human mast cells with anti-IgE. J. Immunol. 129:1982;1627-1631.
43. Russo T., Zambrano N., Esposito F., Ammendola R., Cimino F., Fiscella M., Jackman J., O'Connor P.M., Anderson C.W., Appella E. A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J. Biol. Chem. 270:1995;29386-29391.
44. 2-mediated cellular arrest and death. Cancer Res. 56:1996;475-479.
45. Fuse T., Yamada K., Asai K., Kato T., Nakanishi M. Heat shock-mediated cell cycle arrest is accompanied by induction of p21 CKI. Biochem. Biophys. Res. Commun. 225:1996;759-763.
46. Resnicoff M., Sell C., Rubini M., Coppola D., Ambrose D., Baserga R., Rubin R. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-I (IGF-I) receptor are non-tumorigenic and induce regression of wild-type tumors. Cancer Res. 54:1994;2218-2222.
47. Resnicoff M., Abraham D., Yutanawiboonchai W., Rotman H.L., Kajstura J., Rubin R., Zoltick P., Baserga R. The insulin-like growth factor-I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55:1995;2463-2469.